XML 1060 R49.htm IDEA: XBRL DOCUMENT v3.8.0.1
SUBSEQUENT EVENTS (Details Narrative)
 1 Months Ended 12 Months Ended
Apr. 19, 2018
CAD ($)
Apr. 18, 2018
USD ($)
shares
Mar. 16, 2018
USD ($)
Feb. 20, 2018
USD ($)
Integer
Dec. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Mar. 14, 2018
USD ($)
Line of credit facility, borrowed amount         $ 3,110,714    
Interest Paid         $ 130,531 $ 30,396  
Subsequent Event [Member] | Chief Executive Officer [Member]              
Due to related party     $ 246,010       $ 371,383
Subsequent Event [Member] | Mr. Siokas [Member]              
Common stock shares reserved | shares   1,000,000          
Subsequent Event [Member] | Advisory Agreement [Member] | Synthesis [Member]              
Description for advisory agreement  

SkyPharm S.A. entered into a ten-year Advisory Agreement with Synthesis Management Limited (the “Advisor”). The Advisor was retained to assist SkyPharm to secure corporate finance capital. The Advisor shall be paid €104,000 per year during the ten-year term, all of which have been pre-paid by SkyPharm for future financing services

          
Subsequent Event [Member] | Loan Facility Agreement [Member] | Synthesis [Member]              
Line of credit facility, borrowed amount   $ 3,117,287          
Line of credit facility, interest rate   10.00%          
Description for the consideration receivable under agreement   The Loan Facility permits prepayment and is due upon the earlier of (i) 75 days following demand of the Lender; or (ii) December 31, 2021, as amended.          
Interest Paid   $ 136,800          
Percents of quarterly Libor Payments   4.00%          
Percent of default interest   2.00%          
Line of credit facility, interest rate restated description   Until January 1, 2018, advances under the Loan Facility accrued interest at ten percent (10%) per annum from the applicable date of each drawdown and require quarterly interest payments. The interest rate was restated as of January 1, 2018 to four (4%) percent plus quarterly Libor Payments, plus two (2%) percent default interest on unpaid amounts in addition to the interest rate          
Subsequent Event [Member] | Distribution and Equity Agreement [Member] | Marathon [Member]              
Description for the term of agreement The Agreement is to remain in effect indefinitely unless Marathon fails to provide Market Competitive (as defined) product pricing and Marathon has not become profitable within five (5) years of this Agreement            
Description for the consideration receivable under agreement Following a thirty (30) day due diligence period, and subject to satisfactory due diligence of the Company, Marathon shall: (a) grant the Company a 33 1/3% equity interest in Marathon as partial consideration for the Company’s distribution services; and (b) make a cash payment of CAD $2,000,000 to the Company, subject to repayment by the Company in Common Shares of the Company if it fails to meet certain performance milestones            
Amount receivable upon satisfactory due diligence $ 2,000,000            
Description for the additional consideration receivable under agreement The Company is entitled to receive an additional CAD $2,750,000 upon the Company’s receipt of gross sales of CAD $6,500,000 and an additional CAD $2,750,000 upon receipt of gross sales of CAD $13,000,000. The Company was also given the right to nominate one director to the Marathon Board of Directors            
Subsequent Event [Member] | Distribution and Equity Agreement [Member] | Marathon [Member] | Target 2 [Member]              
Additional consideration receivable upon meeting of target $ 2,750,000            
Gross sales target for consideration receivable 13,000,000            
Subsequent Event [Member] | Distribution and Equity Agreement [Member] | Marathon [Member] | Target 1 [Member]              
Additional consideration receivable upon meeting of target 2,750,000            
Gross sales target for consideration receivable $ 6,500,000            
Subsequent Event [Member] | Third Party Loan Agreement [Member]              
Line of credit facility, borrowed amount     $ 1,845,072        
Line of credit facility, interest rate     4.70%        
Line of credit facility, maturity date     Mar. 16, 2019        
Subsequent Event [Member] | Amendment and Exchange of Agreements [Member] | New senior convertible note [Member]              
Number of agreements | Integer       2      
Maturity date, description       The New Note shall not be convertible into shares of the Company’s common stock (the “Common Stock”) until April 20, 2018      
Description for the payment of installments       All future cash installment payments under such New Note will be made at a redemption price equal to 112% of the applicable installment amount      
Description for the obligation to deliver predelivery shares       The Company’s existing obligation to initially deliver predelivery shares of its common stock to the holder of such New Note is deferred until April 20, 2018      
Description for the redemption of the note       At any time on or before June 20, 2018, the Company has the right, at its option, to redeem all, or any part, of the amounts then outstanding under such New Note in cash at redemption price equal to 125% of such amounts then outstanding under such New Note      
Senior debt       $ 3,350,000      
Subsequent Event [Member] | Amendment and Exchange of Agreements 1 [Member] | New senior convertible note [Member]              
Senior debt       2,791,668      
Subsequent Event [Member] | Amendment and Exchange of Agreements 2 [Member] | New senior convertible note [Member]              
Senior debt       $ 558,332